NCT00299221View on ClinicalTrials.gov

Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients

PHASE4CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

June 30, 2009

Study Completion Date

December 31, 2009

Conditions

Immunosuppression

Interventions

DRUG

Tacrolimus

tacrolimus

DRUG

combination therapy

MMF

Trial Locations (2)

10029

Mt. Sinai Cardiovascular Institute, New York

07112

Newark Beth Israel Medical Center, Newark

Sponsors

Collaborators (1)

Astellas Pharma Inc

All Listed Sponsors

collaborator

Astellas Pharma Inc

INDUSTRY

lead

Newark Beth Israel Medical Center

OTHER